Perspectives in the vaccine development against Opisthorchis viverrini liver fluke
Abstract Liver flukes, Opisthorchis viverrini, infect around 10 million individuals in Southeast Asia, alone, and cause 26,000 deaths in the region per year. Despite being classified as a Group 1 carcinogen, and presenting one of the leading causes of cholangiocarcinoma in epidemic areas, O. viverri...
Main Authors: | Ahmed O. Shalash, Mariusz Skwarczynski, Istvan Toth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-09-01
|
Series: | MedComm – Biomaterials and Applications |
Subjects: | |
Online Access: | https://doi.org/10.1002/mba2.21 |
Similar Items
-
Silencing of Opisthorchis viverrini Tetraspanin Gene Expression Results in Reduced Secretion of Extracellular Vesicles
by: Sujittra Chaiyadet, et al.
Published: (2022-02-01) -
Endemicity of Opisthorchis viverrini Liver Flukes, Vietnam, 2011–2012
by: Jitra Waikagul, et al.
Published: (2014-01-01) -
The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma
by: Jin Peng, et al.
Published: (2014-12-01) -
Epidemiology of Opisthorchis viverrini in an endemic area of Thailand, an integrative approach
by: Prakobwong S., et al.
Published: (2017-12-01) -
Monoclonal Antibodies Targeting an <i>Opisthorchis viverrini</i> Extracellular Vesicle Tetraspanin Protect Hamsters against Challenge Infection
by: Wuttipong Phumrattanaprapin, et al.
Published: (2021-07-01)